AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
Elevance Health Appoints Steve Collis to Board of Directors
ByAinvest
Friday, Aug 1, 2025 2:52 pm ET1min read
Elevance Health's board appoints Steve Collis as a new director, effective August 1. Collis brings extensive healthcare and leadership experience from Cencora, where he served as Executive Chairman. He will join the company's Audit and Finance Committees, highlighting the board's commitment to governance excellence and strategic board refreshment. Collis will support Elevance Health's focus on delivering high-quality care, driving innovation, and creating value for consumers.
INDIANAPOLIS – July 2, 2025 – Elevance Health (NYSE: ELV) has announced the appointment of Steve Collis as a new director, effective August 1. Collis will serve on the company's Audit and Finance Committees, underscoring Elevance Health's commitment to governance excellence and strategic board refreshment [1].Collis, who currently serves as Executive Chairman of the Board of Cencora (formerly AmerisourceBergen), brings extensive experience in healthcare operations and long-term value creation. He has held key executive leadership positions at Cencora, including President and Chief Executive Officer from 2011 to 2024. His tenure saw significant strategic transformation, expanding the company's global reach and deepening its capabilities across the pharmaceutical and healthcare supply chain [1].
Elevance Health's board chair, Ramey Peru, commented, "Steve brings a distinguished record of leadership, transformation, and operational excellence. His insights will support our continued focus on delivering high-quality care, driving innovation, and creating enduring value for the people and communities we serve" [1].
Collis's appointment reflects Elevance Health's ongoing commitment to thoughtful board evolution and sound governance. This move is part of the company's strategy to ensure the board has the right experience to support its growth in a changing market [1].
Elevance Health serves over 109 million consumers through a diverse portfolio of industry-leading medical, pharmacy, behavioral, clinical, home health, and complex care solutions. The company's purpose is to improve the health of humanity by connecting consumers, families, and communities to the care, support, and resources they need [2].
References:
[1] https://www.elevancehealth.com/newsroom/elevance-health-board-welcomes-steve-collis-as-new-director
[2] https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/what-elevance-health-elvs-lowered-2025-outlook-and-board-ref
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet